154 related articles for article (PubMed ID: 7595736)
21. Combined modality therapy for stage II and stage III pancreatic carcinoma.
Kamthan AG; Morris JC; Dalton J; Mandeli JP; Chesser MR; Leben D; Cooperman A; Bruckner HW
J Clin Oncol; 1997 Aug; 15(8):2920-7. PubMed ID: 9256136
[TBL] [Abstract][Full Text] [Related]
22. Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome.
Pisters PW; Wolff RA; Janjan NA; Cleary KR; Charnsangavej C; Crane CN; Lenzi R; Vauthey JN; Lee JE; Abbruzzese JL; Evans DB
J Clin Oncol; 2002 May; 20(10):2537-44. PubMed ID: 12011133
[TBL] [Abstract][Full Text] [Related]
23. 125I interstitial implant, precision high-dose external beam therapy, and 5-FU for unresectable adenocarcinoma of pancreas and extrahepatic biliary tree.
Dobelbower RR; Merrick HW; Ahuja RK; Skeel RT
Cancer; 1986 Nov; 58(10):2185-95. PubMed ID: 3756765
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of external-beam radiation therapy plus 5-fluorouracil (5-FU) versus external-beam radiation therapy plus hycanthone (HYC) in confined, unresectable pancreatic cancer.
Earle JD; Foley JF; Wieand HS; Kvols LK; McKenna PJ; Krook JE; Tschetter LK; Schutt AJ; Twito DI
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):207-11. PubMed ID: 8270443
[TBL] [Abstract][Full Text] [Related]
25. [3D-Ct-planned interstitial HDR brachytherapy + percutaneous irradiation and chemotherapy in inoperable pancreatic carcinoma. Methods and clinical outcome].
Pfreundner L; Baier K; Schwab F; Willner J; Bratengeier K; Flentje M; Feustel H; Fuchs KH
Strahlenther Onkol; 1998 Mar; 174(3):133-41. PubMed ID: 9524622
[TBL] [Abstract][Full Text] [Related]
26. Preliminary survivorship report on combined intraoperative radiation and hyperthermia treatments for unresectable pancreatic adenocarcinoma.
Ashayeri E; Bonney G; DeWitty RL; Goldson AL; Leffall LD; Thomas JN
J Natl Med Assoc; 1993 Jan; 85(1):36-40. PubMed ID: 8426382
[TBL] [Abstract][Full Text] [Related]
27. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group.
Moertel CG; Gunderson LL; Mailliard JA; McKenna PJ; Martenson JA; Burch PA; Cha SS
J Clin Oncol; 1994 Jan; 12(1):21-7. PubMed ID: 8270979
[TBL] [Abstract][Full Text] [Related]
28. Long-term results of combined modality treatment with I-125 implantation for carcinoma of the pancreas.
Mohiuddin M; Rosato F; Barbot D; Schuricht A; Biermann W; Cantor R
Int J Radiat Oncol Biol Phys; 1992; 23(2):305-11. PubMed ID: 1587751
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic cancer: treatment with neutron irradiation alone and with chemotherapy.
Cohen L; Hendrickson FR; Lennox AJ; Kroc TK; Hatcher MA; Bennett BR
Radiology; 1996 Sep; 200(3):627-30. PubMed ID: 8756907
[TBL] [Abstract][Full Text] [Related]
30. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
[TBL] [Abstract][Full Text] [Related]
31. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience.
Seydel HG; Stablein DM; Leichman LP; Kinzie JJ; Thomas PR
Cancer; 1990 Apr; 65(7):1478-82. PubMed ID: 2138054
[TBL] [Abstract][Full Text] [Related]
32. Radiotherapy, local control and survival in carcinomas of the exocrine pancreas.
Cellini N; Trodella L; Valentini V; Doglietto GB; Morganti AG; Ziccarelli P; Alfieri S; Bossola M; Brizi MG; Crucitti F
Rays; 1998; 23(3):528-34. PubMed ID: 9932470
[TBL] [Abstract][Full Text] [Related]
33. Dose escalation of concurrent hypofractionated radiotherapy and continuous infusion 5-FU-chemotherapy in advanced adenocarcinoma of the pancreas.
Zimmermann FB; Jeremic B; Lersch C; Geinitz H; Hennig M; Molls M
Hepatogastroenterology; 2005; 52(61):246-50. PubMed ID: 15783041
[TBL] [Abstract][Full Text] [Related]
34. Intraoperative radiotherapy in the combination of adjuvant chemotherapy for the treatment of pT3N0M0 rectal cancer after radical surgery.
Zhang Q; Tey J; Yang Z; Li P; Peng L; Jiang R; Xiong F; Fu S; Lu JJ
Am J Clin Oncol; 2014 Feb; 37(1):8-12. PubMed ID: 22892433
[TBL] [Abstract][Full Text] [Related]
35. [Radiotherapeutic strategies in the multimodal therapy of resectable and nonresectable pancreatic carcinoma].
Wiegel T; Runkel N; Frommhold H; Rübe C; Hinkelbein W
Strahlenther Onkol; 2000 Jul; 176(7):299-306. PubMed ID: 10962995
[TBL] [Abstract][Full Text] [Related]
36. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114.
Tepper JE; O'Connell MJ; Petroni GR; Hollis D; Cooke E; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA
J Clin Oncol; 1997 May; 15(5):2030-9. PubMed ID: 9164215
[TBL] [Abstract][Full Text] [Related]
38. Current approaches to multimodality management of advanced pancreatic cancer.
Douglass HO
Hepatogastroenterology; 1993 Oct; 40(5):433-42. PubMed ID: 8270232
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): improved treatment for gastric adenocarcinoma.
Weese JL; Harbison SP; Stiller GD; Henry DH; Fisher SA
Surgery; 2000 Oct; 128(4):564-71. PubMed ID: 11015089
[TBL] [Abstract][Full Text] [Related]
40. The role of intraoperative therapy by electron beam and combination of adjuvant chemotherapy and external radiotherapy in carcinoma of the pancreas.
Fossati V; Cattaneo GM; Zerbi A; Galli L; Bordogna G; Reni M; Parolini D; Carlucci M; Bissi A; Staudacher C
Tumori; 1995; 81(1):23-31. PubMed ID: 7754537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
